Evaluation and Management of Continuous Vomiting
For continuous vomiting, immediately assess for life-threatening emergencies (acute abdomen, bowel obstruction, mesenteric ischemia, pancreatitis, myocardial infarction), then systematically differentiate between acute (<7 days) versus chronic (≥4 weeks) presentations, with specific attention to cyclic vomiting syndrome (CVS) and cannabinoid hyperemesis syndrome (CHS) as underdiagnosed causes. 1, 2
Initial Emergency Assessment
First, rule out surgical emergencies and life-threatening conditions requiring immediate intervention 2:
- Acute abdomen with peritoneal signs
- Bowel obstruction (distension, absent bowel sounds)
- Mesenteric ischemia (severe pain out of proportion to exam)
- Pancreatitis (epigastric pain radiating to back)
- Myocardial infarction (especially in older adults with risk factors)
Acute vs. Chronic Differentiation
Acute Vomiting (<7 days)
Typically self-limited and requires minimal workup in absence of alarm features 3:
- Common causes: Gastroenteritis, viral syndromes, foodborne illness, acute migraine, vestibular disturbances, early pregnancy, medication adverse effects
- Management: Symptomatic treatment with antiemetics (serotonin or dopamine antagonists), fluid/electrolyte replacement, small frequent meals 3
Chronic Vomiting (≥4 weeks)
Requires systematic evaluation with broader differential 4, 5:
Critical Diagnostic Questions
1. Cannabis Use History
Ask specifically about frequency and duration 2:
- Duration >1 year before symptom onset
- Frequency >4 times per week on average
- If positive: Consider CHS, especially if compulsive hot bathing behavior present
2. Pattern Recognition for CVS
Look for stereotypical episodic pattern 1:
- Four distinct phases: Inter-episodic (symptom-free), prodromal (~65% experience this, median 1 hour), emetic (acute vomiting), recovery
- Frequency: ≥3 episodes annually
- Stereotypic presentation: Same pattern each episode
- Prodromal symptoms: Nausea, abdominal pain before vomiting onset
- Associated features: Migraine history (strong association), anxiety, depression, autonomic dysfunction 6
3. Timing Relative to Meals
- Immediate post-meal: Consider rumination syndrome, obstruction
- Delayed (>1 hour): Consider gastroparesis
- Unrelated to meals: Consider CVS, CHS, functional disorders
4. Pregnancy Status
Must be excluded in all women of childbearing age 7
Diagnostic Workup Algorithm
Minimal Recommended Testing 1, 6:
- Upper endoscopy (exclude structural abnormalities)
- Abdominal imaging (CT or ultrasound based on clinical suspicion)
- Basic metabolic panel (electrolytes, glucose, calcium, renal function)
- Pregnancy test (if applicable)
- Gastric emptying study (if gastroparesis suspected after normal structural evaluation)
Additional Testing Based on Clinical Suspicion 4, 5:
- Neurologic evaluation if headache, focal deficits, or signs of increased intracranial pressure
- Vestibular testing if vertigo prominent
- Medication/toxin review (opioids, chemotherapy, digoxin, etc.)
Management by Diagnosis
Cannabinoid Hyperemesis Syndrome (CHS)
Acute management 2:
- Topical capsaicin 0.1% cream (activates TRPV1 receptors)
- Benzodiazepines, haloperidol, promethazine, olanzapine, or ondansetron
- Avoid opioids (worsen nausea, high addiction risk)
Long-term management 2:
- Cannabis cessation is essential (symptoms resolve after 6 months abstinence or duration of 3 typical cycles)
- Amitriptyline 75-100 mg at bedtime (start 25 mg, titrate weekly)
- Psychological support for cannabis use disorder (high recidivism rate)
Cyclic Vomiting Syndrome (CVS)
- First-line: Amitriptyline (tricyclic antidepressant)
- Second-line: Topiramate (antiepileptic)
- Refractory cases: Aprepitant
Abortive therapy during episodes 6:
- Triptans (especially if migraine association)
- Ondansetron (antiemetic)
- Sedation as needed
- Anxiety and depression management
- Autonomic dysfunction treatment
- Migraine prophylaxis
Gastroparesis
If delayed gastric emptying confirmed:
- Dietary modifications (small, frequent meals; low fat, low fiber)
- Prokinetic agents
- Antiemetics
Functional Chronic Nausea/Vomiting
If normal gastric emptying and no structural cause 4:
- Serotonin antagonists (ondansetron)
- Dopamine antagonists (metoclopramide, prochlorperazine)
- Neuromodulators (tricyclic antidepressants)
Critical Pitfalls to Avoid
Missing CHS diagnosis: CVS prevalence is ~2% in US population, but CHS is rising with cannabis legalization 1, 2. Always ask about cannabis use explicitly.
Years of diagnostic delay: CVS patients average years before diagnosis, undergo unnecessary procedures, and ~50% visit ED annually 1. Early pattern recognition is crucial.
Opioid use in CHS: Worsens symptoms and creates addiction risk 2.
Inadequate cannabis cessation counseling: Recidivism is high; co-management with psychology/psychiatry often necessary 2.
Ignoring psychiatric comorbidities: Anxiety and depression are extremely common in both CVS and CHS and must be addressed for successful outcomes 1, 2, 6.
Quality of Life Impact
Both CVS and CHS significantly impair quality of life, with 1 in 3 adults with CVS becoming disabled 1. Early recognition and appropriate treatment reduce healthcare utilization and improve outcomes 1. The economic burden is substantial, making prompt diagnosis and targeted therapy essential 5.